dose-dependent toxicity

Dose-dependent toxicity is harm that grows predictably as the dose grows — turn the dial up, and the damage gets worse in a way you can largely anticipate. It is the well-behaved, 'rule-following' kind of toxicity, in contrast to allergic or idiosyncratic reactions that ignore dose entirely.

Mechanistically, this is usually an extension of the drug's own pharmacology or that of its metabolites: above some threshold, the same action that produces the effect begins to overwhelm a protective system or to act in tissues where it is unwanted. Because it tracks the dose, it corresponds to the Type A ('augmented') category of adverse reactions and is generally reversible by reducing or stopping the drug.

Its predictability is what makes it manageable. Toxicologists can map a dose-response relationship for the harmful effect just as they do for the beneficial one, and the gap between the two curves defines the therapeutic index and therapeutic window. Drugs with a narrow window — digoxin, warfarin, aminoglycosides, lithium — are precisely those where small dose increases push patients into toxicity, justifying blood-level monitoring.

The honest contrast is important for patients and clinicians: most everyday drug toxicity is dose-dependent and avoidable through careful dosing, but a separate class of dangerous reactions is not dose-dependent at all and cannot be prevented by simply using 'a small dose'.